As an inventor company with the mission "Bayer: Science For A Better Life," Bayer continues to focus on its core competencies in the development of new solutions in the fast-growing, innovation-driven areas of health care, nutrition and high-tech materials. Based on our innovative capability, we are pursuing a strategy of sustainable and profitable growth that adds corporate value.
Across all of our businesses we are striving to further reinforce our portfolio, consistently capitalize on growth opportunities and continuously raise productivity.
Portfolio: We aim to continue playing leading roles in lucrative markets and to steadily expand the strong positions we already hold.
Growth: We are systematically investing in our innovative capabilities, maximizing the value of our research and development pipeline and realizing opportunities in the emerging markets, particularly China and Brazil.
Productivity: Based on the maxim "More innovation – less administration," we are continuing our efforts to improve efficiency by simplifying our structures and processes. By 2013 we aim to be saving €800 million a year, half of which is to be reinvested in research and development and the continuing expansion of our business in the emerging markets.
You are leaving the Bayer AG website.
Bayer AG is not responsible for the information on the website to which you are linking.
